Omslagafbeelding van de show Compounded Semaglutide — Is It Safe?

Compounded Semaglutide — Is It Safe?

Podcast door Inception Point AI

Engels

Gezondheid & Persoonlijke Ontwikkeling

Daarna € 9,99 / maand. Elk moment opzegbaar.

  • 20 uur luisterboeken / maand
  • Podcasts die je alleen op Podimo hoort
  • Gratis podcasts

Over Compounded Semaglutide — Is It Safe?

Dr. Ben Synth exposes the hidden dangers of compounded semaglutide through FDA data, quality control failures, and hundreds of adverse events. Discover why the cheaper alternative to brand-name weight-loss drugs may carry serious risks—from dosing errors to contaminated ingredients—and what patients need to know now. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.

Alle afleveringen

4 afleveringen

aflevering Compounded Semaglutide — Is It Safe? - Separate fact from fiction with Dr. Ben Synth artwork

Compounded Semaglutide — Is It Safe? - Separate fact from fiction with Dr. Ben Synth

Dr. Ben Synth investigated the booming compounded semaglutide market and uncovered hundreds of adverse event reports, alarming impurity levels, and dosing errors hidden in an unregulated gray zone. This series exposes the supply chain risks, mystery ingredients, and legal loopholes behind those cheaper weight-loss injections. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 apr 2026 - 39 s
aflevering Compounded Semaglutide — Is It Safe? - The Shortage Loophole: A Billion-Dollar Wild West artwork

Compounded Semaglutide — Is It Safe? - The Shortage Loophole: A Billion-Dollar Wild West

Ben Synth examines how the FDA's drug shortage exemption allowed compounding pharmacies to produce cheaper semaglutide alternatives during the Ozempic and Wegovy shortage, creating a billion-dollar gray market with serious safety risks, dosing errors, and regulatory gaps that left millions of patients navigating uncertain ground. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 apr 2026 - 26 min
aflevering Compounded Semaglutide — Is It Safe? - What's Actually in That Vial artwork

Compounded Semaglutide — Is It Safe? - What's Actually in That Vial

Ben Synth examines disturbing findings from Novo Nordisk testing: some compounded semaglutide samples contained 33% impurities, including formaldehyde, trace metals, and banned substances like BPC-157. We discuss supply chain risks, unvetted foreign suppliers, non-pharmaceutical grade ingredients, sterility failures, and fraudulent labeling that distinguish compounded versions from FDA-approved Ozempic and Wegovy. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 apr 2026 - 18 min
aflevering Compounded Semaglutide — Is It Safe? - 605 Adverse Events and Counting artwork

Compounded Semaglutide — Is It Safe? - 605 Adverse Events and Counting

Ben Synth examines the dangers of compounded semaglutide, a cheaper alternative to FDA-approved weight loss drugs like Ozempic and Wegovy. The episode covers over 600 adverse events reported to the FDA, including severe overdoses, hospitalizations, and life-threatening complications. Through detailed analysis of regulatory data and clinical reports, Ben explores dosing errors, quality control failures, and the risks patients face. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 apr 2026 - 20 min
Meld je aan om te luisteren
Super app. Onthoud waar je bent gebleven en wat je interesses zijn. Heel veel keuze!
Super app. Onthoud waar je bent gebleven en wat je interesses zijn. Heel veel keuze!
Makkelijk in gebruik!
App ziet er mooi uit, navigatie is even wennen maar overzichtelijk.

Kies je abonnement

Meest populair

Tijdelijke aanbieding

Premium

20 uur aan luisterboeken

  • Podcasts die je alleen op Podimo hoort

  • Geen advertenties in Podimo shows

  • Elk moment opzegbaar

2 maanden voor € 1
Daarna € 9,99 / maand

Begin hier

Premium Plus

Onbeperkt luisterboeken

  • Podcasts die je alleen op Podimo hoort

  • Geen advertenties in Podimo shows

  • Elk moment opzegbaar

Probeer 7 dagen gratis
Daarna € 13,99 / maand

Probeer gratis

Alleen bij Podimo

Populaire luisterboeken

Veelgestelde vragen

Meer vragen & antwoorden
Begin hier

2 maanden voor € 1. Daarna € 9,99 / maand. Elk moment opzegbaar.